Changing Paradigms in Insomnia: Improving Patient Wake Time and Quality of Life Through Better Sleep

 
Release Date: May 31, 2019
Last Reviewed: September 13, 2019
Expiration Date: October 31, 2020
Time to Complete Activity:  1.5 hours
 
Faculty
Paul P. Doghramji, MD
Senior Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, PA
 
Karl Doghramji, MD
Professor of Psychiatry, Neurology, and Medicine
Medical Director, Jefferson Sleep Disorders Center
Program Director, Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, PA
 
David N. Neubauer, MD
Associate Professor
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, MD
 
This activity is provided by Paradigm Medical Communications, LLC.
 
Target Audience
This activity has been designed to address the educational needs of physicians, nurse practitioners, and PAs specializing in internal medicine, family medicine, and primary care. It may also be of benefit to psychiatry clinicians and other healthcare providers who are interested in the treatment and care of patients with insomnia.

Statement of Need
Insomnia is among the most common disorders encountered by primary care clinicians, with an estimated 5.5 million annual visits. Unfortunately, training regarding screening, assessment, and management is often insufficient. In addition, several medications commonly prescribed are not indicated for insomnia, which leads to suboptimal outcomes. Traditional agents have significant drawbacks, such as adverse events, potential for abuse, memory disruption, and more. Newer and emerging agents more effectively reduce wakefulness throughout the night without daytime safety issues and with reduced adverse events. This web activity is presented by 3 sleep experts, and will feature a didactic lecture with the most current data and case-based presentations as well as a moderated Q&A session.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Develop appropriate treatment plans for insomnia as an independent disorder, including consideration of comorbid conditions
  • Review the tolerance and dependency issues and adverse events associated with available insomnia therapies that affect treatment tolerability
  • Summarize safety and efficacy data for newer and investigational agents for the treatment of insomnia

Agenda
  • The Face of Insomnia in the Primary Care Setting
  • Case Study
  • Definitions and Background
  • Neurophysiology of Normal Sleep and Wakefulness
  • Recommendations for Management of Insomnia
  • Insomnia: Traditional Treatment Options
  • New and Emerging Treatment Options
  • Q&A
Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
 
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
 
Disclosure of Commercial Support
Supported by an independent educational grant from Eisai.
 
Instructions for Participation
To receive a CME certificate of participation, you should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation
A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
 
There is no fee required for participation in this activity.
 
Hardware/Software Requirements
This certified CME activity is designed using HTML5 video. As you navigate the video using the supplied controls, the slides will sync to the speaker.
 
Supported Browsers:
For Desktops (Windows/Mac)
Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
 
For Tablets (iPad/Android/Surface)
iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher

Adobe Reader
This activity is in Adobe Acrobat PDF format. To view the activity, you will need Adobe Reader. If you do not have Adobe Reader installed on your computer, please visit http://get.adobe.com/reader/ to install a free version of Adobe Reader.
 
Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.
 
Disclosures
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
 
Faculty
Paul P. Doghramji, MD
Speakers Bureau: Merck & Co, Inc
Retained Consultant: Eisai Inc; Harmony Biosciences, LLC; Jazz Pharmaceuticals, Inc
Stockholder: Pfizer Inc
 
Karl Doghramji, MD
Grant/Research Support: Harmony Biosciences, LLC; Merck & Co, Inc; Teva Pharmaceutical
Retained Consultant: Eisai, Inc; Harmony Biosciences, LLC; Jazz Pharmaceuticals, Inc; Merck & Co, Inc; Pfizer Inc
Stockholder: Merck & Co, Inc
 
David N. Neubauer, MD
Retained Consultant: Eisai Inc; Purdue LP; Teva Pharmaceutical
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty members, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.
 
As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the faculty members, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
 
Privacy policy
Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
 
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2019 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.